Daina Lim

Daina Lim is a highly skilled risk management scientist specializing in patient safety and risk management for marketed and developmental products. With a PhD in Oncology from the National University of Singapore and extensive experience in therapeutic areas such as Virology and Immunotherapy, Daina has held various positions at Gilead Sciences, leading safety-related initiatives and managing clinical trials. Currently serving as the Director of Patient Safety Risk Management at Gilead Sciences, Daina previously contributed to significant projects in medical surveillance safety and pharmacovigilance. Their research background includes postdoctoral work at the University of Cambridge, focusing on immunology and immuno-oncology.